Sign in
4

Changes in Ownership

Cabaletta Bio, Inc. Filed Acc 0000950170-25-074811

Options or other derivatives

  • Chief Business Officer acquired 403,416 shares (grant or award)
  • Chief Business Officer returned 403,416 shares (to the company)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
Das Arun Chief Business Officer 2025-05-19 Returned to the company · Stock Option (Right to Buy) −18,416 0 D
Das Arun Chief Business Officer 2025-05-19 Grant or award · Stock Option (Right to Buy) +18,416 18,416 D
Das Arun Chief Business Officer 2025-05-19 Returned to the company · Stock Option (Right to Buy) −35,000 0 D
Das Arun Chief Business Officer 2025-05-19 Grant or award · Stock Option (Right to Buy) +35,000 35,000 D
Das Arun Chief Business Officer 2025-05-19 Returned to the company · Stock Option (Right to Buy) −100,000 0 D
Das Arun Chief Business Officer 2025-05-19 Grant or award · Stock Option (Right to Buy) +100,000 100,000 D
Das Arun Chief Business Officer 2025-05-19 Returned to the company · Stock Option (Right to Buy) −150,000 0 D
Das Arun Chief Business Officer 2025-05-19 Grant or award · Stock Option (Right to Buy) +150,000 150,000 D
Das Arun Chief Business Officer 2025-05-19 Returned to the company · Stock Option (Right to Buy) −100,000 0 D
Das Arun Chief Business Officer 2025-05-19 Grant or award · Stock Option (Right to Buy) +100,000 100,000 D
Loading xslF345X05/ownership.xml…